Thyrocare Technologies Share Price | Thyrocare Technologies Stock Screener
THYROCARE
Healthcare Service Provider
Share Price NSE
₹564.25
▲
19.00 (3.48%)
Share Price BSE
₹564.95
▲
19.40 (3.56%)
As of July 24, 2026, the Thyrocare Technologies share price (NSE: THYROCARE) is ₹564.25 on NSE and ₹564.95 on BSE, up 3.48% from the previous close, with shares trading between ₹543.00 and ₹597.60, and a 52-week range of ₹349.55–₹1,591.90.
Analyse THYROCARE price movement history and track historical price performance.
Use the Thyrocare Technologies stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Thyrocare Technologies Market Cap
₹8,958.62 Cr.
THYROCARE P/E Ratio (TTM)
54.28
Thyrocare Technologies P/B Ratio
17.24
EPS (TTM)
₹10.27
Dividend Yield
2.52%
Debt to Equity
0.07
THYROCARE 52 Week High
₹1591.90
Thyrocare Technologies 52 Week Low
₹349.55
Operating Margin
34.00%
Profit Margin
21.40%
THYROCARE Revenue (TTM)
₹229.00
EBITDA
₹80.00
Net Income
₹49.00
Total Assets
₹747.00
Total Equity
₹586.00
Thyrocare Technologies Share Price Chart
Screen Thyrocare Technologies share price with an interactive chart. Analyse THYROCARE price trends and volatility across different timeframes.
Thyrocare Technologies Company Profile - Fundamental Screener
Screen Thyrocare Technologies company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for THYROCARE shares.
Sector
Healthcare Services
Industry
Healthcare Service Provider
Sub-Sector
Healthcare Service Provider
Segment
E
ISIN
INE594H01019
Thyrocare Technologies Balance Sheet Screener
Screen THYROCARE balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 747 | 693 | 644 | 633 | 608 | 546 | 471 | 475 | 479 | 438 |
| Current Assets | 372 | 338 | 279 | 273 | 270 | 240 | 152 | 136 | 142 | 150 |
| Fixed Assets | 317 | 297 | 306 | 294 | 285 | 253 | 269 | 294 | 299 | 259 |
| Liabilities | ||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 51 | 24 | 26 | 20 | 17 | 23 | 23 | 19 | 15 | 12 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 586 | 547 | 528 | 535 | 527 | 427 | 367 | 435 | 443 | 408 |
| Share Capital | 159 | 53 | 53 | 53 | 53 | 53 | 53 | 53 | 54 | 54 |
| Reserves & Surplus | 354 | 439 | 440 | 463 | 474 | 374 | 314 | 382 | 390 | 354 |
Thyrocare Technologies Income Statement Screener - Profit & Revenue Analysis
Screen Thyrocare Technologies income statement and profit fundamentals.
Analyze THYROCARE quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Thyrocare Technologies share price evaluation.
| Item | 2026-Mar | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar | 2023-Dec | 2023-Sept | 2023-Jun | 2023-Mar | 2022-Dec | 2022-Sept |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 229 | 201 | 220 | 198 | 192 | 170 | 180 | 161 | 158 | 138 | 151 | 136 | 140 | 131 | 137 |
| Expenses | 149 | 144 | 145 | 135 | 130 | 124 | 129 | 115 | 121 | 103 | 111 | 100 | 111 | 100 | 103 |
| EBITDA | 80 | 57 | 75 | 63 | 62 | 46 | 51 | 46 | 37 | 35 | 40 | 36 | 29 | 31 | 33 |
| Operating Profit % | 34.00% | 26.00% | 33.00% | 30.00% | 30.00% | 25.00% | 27.00% | 27.00% | 22.00% | 23.00% | 25.00% | 26.00% | 18.00% | 22.00% | 23.00% |
| Depreciation | 14 | 22 | 12 | 11 | 14 | 17 | 13 | 11 | 13 | 14 | 11 | 10 | 11 | 10 | 9 |
| Interest | 2 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Profit Before Tax | 64 | 35 | 63 | 51 | 47 | 28 | 37 | 34 | 23 | 20 | 28 | 25 | 17 | 20 | 24 |
| Tax | 16 | 7 | 15 | 12 | 26 | 9 | 10 | 10 | 6 | 5 | 8 | 8 | 5 | 5 | 8 |
| Net Profit | 49 | 28 | 48 | 38 | 22 | 19 | 26 | 24 | 17 | 15 | 20 | 17 | 13 | 15 | 15 |
| EPS | 2.99 | 1.82 | 9.05 | 7.35 | 4.17 | 3.58 | 4.99 | 4.52 | 3.54 | 2.78 | 3.84 | 3.26 | 2.36 | 2.78 | 3.80 |
Thyrocare Technologies Cash Flow Screener - Liquidity Fundamentals
Screen THYROCARE cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 213 | 191 | 168 | 129 | 113 | 115 | 168 | 100 | 107 | 90 |
| Investing Activities | -23 | -53 | -91 | -39 | -24 | -49 | 1 | -12 | -43 | -42 |
| Financing Activities | -170 | -130 | -85 | -86 | -89 | -62 | -165 | -94 | -64 | -49 |
| Net Cash Flow | 21 | 8 | -9 | 4 | 0 | 5 | 4 | -5 | 0 | -1 |
Thyrocare Technologies Shareholding Pattern Screener
See Thyrocare Technologies shareholding pattern with promoter, FII, and DII holdings.
Check Thyrocare Technologies promoter holding and ownership changes for THYROCARE on TickJournal.
| Item | 2026-Jun | 2026-Mar | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 60.92% | 60.92% | 60.93% | 71.06% | 71.06% | 71.06% | 71.06% | 71.11% |
| FII Holding | 5.44% | 5.37% | 4.95% | 4.85% | 3.23% | 2.41% | 2.77% | 1.93% |
| DII Holding | 20.92% | 20.99% | 20.51% | 13.47% | 14.54% | 14.97% | 14.67% | 14.80% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 10.35% | 10.18% | 10.88% | 8.19% | 8.94% | 9.21% | 9.16% | 9.78% |
| Other Holding | 2.36% | 2.53% | 2.73% | 2.43% | 2.23% | 2.36% | 2.33% | 2.38% |
| Shareholder Count | 73,064 | 73,377 | 77,969 | 54,142 | 54,566 | 57,403 | 56,666 | 59,377 |
Thyrocare Technologies Share Dividend Screener - Share Yield Analysis
Check Thyrocare Technologies dividend history with payout and yield data.
View Thyrocare Technologies dividend details including ex-dates and amounts for THYROCARE stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹14.00 | 2.52% |
| 2025-March | ₹21.00 | 6.01% |
| 2024-March | ₹18.00 | 7.95% |
| 2023-March | ₹18.00 | 9.15% |
| 2022-March | ₹15.00 | 10.47% |
| 2021-March | ₹25.00 | 9.67% |
| 2020-March | ₹5.00 | 1.66% |
| 2019-March | ₹20.00 | 12.08% |
| 2018-March | ₹10.00 | 5.62% |
| 2017-March | ₹10.00 | 5.03% |
Thyrocare Technologies Stock Index Membership
See which indices include Thyrocare Technologies stock.
Check THYROCARE index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
BSE 1000
BSE INDEX BSE HC
BSE INDEX SMLCAP
Thyrocare Technologies Market Events Screener - Corporate Actions
Get Thyrocare Technologies corporate actions including splits, bonuses, and buybacks.
Check Thyrocare Technologies stock events that may affect THYROCARE share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-07-23 | 2026-07-23 | Quarterly Result Announcement | NA | 4.71% |
| 2026-06-30 | 2026-06-30 | Annual General Meeting | NA | 0.58% |
| 2026-06-23 | 2026-06-23 | Dividend | ₹ 7.00 /share | 18.26% |
| 2026-05-07 | 2026-05-07 | Quarterly Result Announcement | NA | 13.28% |
| 2026-01-28 | 2026-01-28 | Quarterly Result Announcement | NA | -4.81% |
| 2025-11-28 | 2025-11-28 | Bonus | 2:1 | -5.76% |
| 2025-10-24 | 2025-10-24 | Dividend | ₹ 7.00 /share | -0.66% |
| 2025-10-14 | 2025-10-14 | Quarterly Result Announcement | NA | 7.05% |
| 2025-07-31 | 2025-07-31 | Annual General Meeting | NA | 27.09% |
| 2025-07-25 | 2025-07-25 | Dividend | ₹ 21.00 /share | 68.16% |
| 2025-07-23 | 2025-07-23 | Quarterly Result Announcement | NA | 2.06% |
| 2025-04-23 | 2025-04-23 | Quarterly Result Announcement | NA | 13.10% |
| 2025-01-23 | 2025-01-23 | Quarterly Result Announcement | NA | -2.22% |
| 2024-10-23 | 2024-10-23 | Quarterly Result Announcement | NA | 7.33% |
| 2024-08-23 | 2024-08-23 | Annual General Meeting | NA | 8.95% |
Thyrocare Technologies Competitors Screener - Peer Comparison
Screen THYROCARE competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Dr. Lal Path Labs | 28,500 | 55.73 | 2,864 | 12.11% | 510 | 55.92 |
| Vijaya Diagnostic Centre | 13,699 | 79.34 | 814 | 16.36% | 182 | 48.41 |
| Metropolis Healthcare | 11,793 | 62.17 | 1,646 | 22.25% | 185 | 55.17 |
| Thyrocare Technologies | 8,959 | 54.28 | 846 | 20.48% | 163 | 59.90 |
| Nephrocare Health Services | 6,286 | 82.61 | 999 | 29.74% | 62 | 39.12 |
| Krsnaa Diagnostics | 1,792 | 17.41 | 773 | 4.05% | 106 | 51.75 |
| Suraksha Diagnostic | 1,359 | 42.71 | 310 | 21.30% | 34 | 41.17 |
| One Global Service Provider | 1,182 | 16.75 | 498 | 237.06% | 69 | 48.61 |
| 3B BlackBio DX | 1,092 | 18.00 | 142 | 27.17% | 61 | 58.62 |
| Health X Platform | 1,012 | -707.89 | 1,319 | 12.68% | -3 | 50.95 |
Thyrocare Technologies Company Announcements - News Screener
Screen THYROCARE latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-07-21 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-07-21 | Board Meeting Intimation for Board Meeting Intimation For Consideration And Approval Of The Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter Ended June 30 2026 | - |
| 2026-07-07 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-06-30 | Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association | - |
| 2026-06-30 | Change In Statutory Auditors Of The Company | - |
| 2026-06-30 | Shareholder Meeting / Postal Ballot-Outcome of AGM | - |
| 2026-06-24 | Closure of Trading Window | - |
| 2026-06-10 | Communication To Shareholders - Intimation On Tax Deduction On Dividend | - |
| 2026-06-05 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-06-04 | Letter Sent To Members Of The Company Providing Web Link For AGM Notice And Annual Report For The FY 2025-26 | - |
| 2026-06-04 | Record Date For The Purpose Of Final Dividend For The FY 2025-26 Is Tuesday June 23 2026 | - |
| 2026-06-04 | Business Responsibility and Sustainability Reporting (BRSR) | - |
| 2026-06-04 | Reg. 34 (1) Annual Report. | - |
| 2026-06-04 | Notice Of 26Th Annual General Meeting Of Thyrocare Technologies Limited To Be Held On Tuesday June 30 2026 At 11:00 A.M. (IST) | - |
| 2026-05-26 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-05-14 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | - |
| 2026-05-12 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | - |
| 2026-05-09 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-05-07 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-05-07 | Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association | - |